Understanding and Addressing the Global Spread of the COVID-19 Infection: A Clinician’s Guide
Credit(s): 1.00 (60 min)
Release Date: Feb 25, 2020
Expiration Date: Feb 25, 2021
CME / AMA PRA Category 1 Credit™
MOC / ABIM MOC Part 2 Credit
The World Health Organization recently declared COVID-19 (Wuhan Coronavirus) as a global health emergency.
This activity will offer clinicians a practical guide with the latest information on prevention, symptoms, diagnosis, and management of COVID-19. Join experts on the COVID-19 infection to learn strategies to deal with this emerging infection.
Click here for a patient resource that you can print out and distribute to answer patients’ FAQ on COVID-19.
Click here for a list of additional questions from clinicians during a live webinar on COVID-19, along with answers from the expert faculty.
Welcome and Introductions
Current Global Status of the COVID-19 Infection
Preventing Coronavirus Transmission
Recognizing, Diagnosing, and Managing COVID-19 Infection
This activity is intended for North American-based clinicians.
This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
At the conclusion of this activity, participants should be able to:
Describe the current global status of the COVID-19 infection
Form evidence-based strategies for prevention of COVID-19 transmission
Recognize the signs and symptoms of COVID-19 infection and perform appropriate diagnostic studies
Develop plans to manage patients with COVID-19 infection
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
Paul D. Biddinger, MD, FACEP
MGH Endowed Chair in Emergency Preparedness
Director, Center for Disaster Medicine
Vice Chairman for Emergency Preparedness
Department of Emergency Medicine, Massachusetts General Hospital
Medical Director for Emergency Preparedness, MGH and Partners Healthcare
Boston, MA, USA
Paul D. Biddinger, MD, FACEP holds the MGH Endowed Chair in Emergency Preparedness and is the Director of the Center for Disaster Medicine and Vice Chairman for Emergency Preparedness in the Department of Emergency Medicine at Massachusetts General Hospital (MGH) in Boston. He is also the Director for Emergency Preparedness at Partners Healthcare and serves as the Director of the Emergency Preparedness Research, Evaluation, and Practice (EPREP) Program at the Harvard T. H. Chan School of Public Health.
Dr. Biddinger serves as a Special Advisor to the Massachusetts Medical Society’s Committee on Preparedness and as a Medical Officer for the MA-1 Disaster Medical Assistance Team (DMAT) in the National Disaster Medical System (NDMS) in the US Department of Health and Human Services (HHS).
An active researcher in the field of emergency preparedness, Dr. Biddinger has lectured nationally and internationally on topics of preparedness and disaster medicine. He has authored numerous articles and book chapters on multiple topics related to emergency medical services and disaster medicine. He completed his undergraduate study in international relations at Princeton University, attended medical school at Vanderbilt University, and completed residency training in emergency medicine at Harvard.
Allison McGeer, MSc, MD, FRCPC
Professor, Dalla Lana School of Public Health
University of Toronto
Allison McGeer, MSc, MD, FRCPC is an adult infectious diseases specialist, a hospital epidemiologist, and a Professor in the Department of Laboratory Medicine and Pathobiology and the Dalla Lana School of Public Health at the University of Toronto. Dr. McGeer was the Director of Infection Prevention and Control for Sinai Health System in Toronto from 1990-2019. Dr. McGeer was the lead investigator for the Toronto hospital SARS outbreak investigation in 2003, an investigator of the first hospital outbreak of MERs in 2013, and shared the role of World Health Organization Focal Point for infection prevention and control in Liberia from October 2014 to January 2015 during the West African Ebola outbreak. She has also served on Canada’s National Advisory Committee on Immunization and the Infection Control Subcommittee of the Ontario Provincial Infectious Diseases Advisory Committee.
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Paul D. Biddinger, MD, FACEP: Nothing to disclose
Allison McGeer, MSc, MD, FRCPC: Nothing to disclose
NON-FACULTY CONTENT CONTRIBUTORS
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Terry Ann Glauser, MD, MPH; Blair St. Amand; Ashley Marostica, MSN, RN, CCM: Nothing to disclose
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT/MOC POINTS
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/MOC activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
In collaboration with
This activity is not supported by any grantor or commercial interest.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.